Phase I multiple ascending dose study of the triple reuptake inhibitor RG 7166
Latest Information Update: 09 Nov 2011
At a glance
- Drugs RG 7166 (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- 09 Nov 2011 New trial record
Latest Information Update: 09 Nov 2011